Articles

Page 66 of 94

P09-21 LB. Deep sequencing of HIV-1 from acute infection: low initial diversity, and rapid but variable CTL escape

Authors: W Fischer, B Keele, T Bhattacharya, C Lo, E Giorgi, P Hraber, T Leitner, C Han, C Gleasner, L Green, B Hahn, G Shaw, B Haynes and B Korber

Citation: Retrovirology 2009 6(Suppl 3):P401

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P08-06 LB. A genome-wide association study of host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the STEP trial

Authors: J Fellay, KV Shianna, ET Cirulli, J McElrath, DR Casimiro, DE Geraghty, N Frahm and DB Goldstein

Citation: Retrovirology 2009 6(Suppl 3):P398

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P05-14 LB. Analysis of virus swarms to identify vaccine immunogens with improved exposure of epitopes recognized by broadly neutralizing antibodies

Authors: P Berman, SM O'Rourke, B Schweighardt, F Sinangil and T Wrin

Citation: Retrovirology 2009 6(Suppl 3):P396

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P19-45. Development of a therapeutic HIV vaccine comprised of autologous dendritic cells loaded with a mixture of lipopeptide HIV antigens

Authors: AJ Cobb, H Mead, M Montes, R Ranganathan, S Burkeholder, J Perry-Finholt, AK Palucka, B King, L Sloan, Y Levy, LK Roberts and J Banchereau

Citation: Retrovirology 2009 6(Suppl 3):P365

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P19-43. Regulatory T cell epitopes in a dendritic cell-targeted HIV vaccine delivery platform

Authors: C Weber, C Weber, L Mosie, H Veelken and W Martin

Citation: Retrovirology 2009 6(Suppl 3):P363

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P19-41. Full-length IMC expressing Renilla luciferase for neutralization assay using PBMC

Authors: A Chenine, E Sanders-Buell, L Wieczorek, J Kim, V Polonis and S Tovanabutra

Citation: Retrovirology 2009 6(Suppl 3):P361

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P19-39. Vaccibodies: a novel vaccine strategy for HIV that target viral antigens to APC

Authors: I Øynebråten, A Fredriksen, D Barouch and B Bogen

Citation: Retrovirology 2009 6(Suppl 3):P359

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P19-37. Replication-defective lymphocytic choriomeningitis virus vectors boost cellular and humoral immunity after DNA or adenovirus vector priming

Authors: LR Flatz, W Kong, S Ko, R Roychoudhuri, L Wang, L Xu, Z Yang, M Honda, DD Pinschewer and GJ Nabel

Citation: Retrovirology 2009 6(Suppl 3):P357

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P19-10. Induction of dendritic cell maturation by a liposomally-delivered multivalent HIV vaccine

Authors: Ali Azizi, Danylo Sirskyj, Amine Saad, Andrei Ogrel, Thanh Le, Catalina Soare, David E Anderson, Jose Torres and Francisco Diaz-Mitoma

Citation: Retrovirology 2009 6(Suppl 3):P330

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P19-08. Immunisation with recombinant HLA class I and II, HIV-1gp140 and SIVp27 antigens elicits protection against SHIV-SF162P4 infection in rhesus macaques

Authors: A Mörner, J Schøller, E Bunnik, M Jansson, L Wehlin, L Bergqvist, E Hansson Pihlainen, O Shaw, T Seidl, Y Wang, LA Bergmeier, M Singh, R Vaughan, G Yang, Y Shao, RT Wyatt…

Citation: Retrovirology 2009 6(Suppl 3):P328

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P19-06. The first hypervariable loop and HIV-1 neutralizing antibodies elicited by gp140 env immunogens

Authors: LK Ching and L Stamatatos

Citation: Retrovirology 2009 6(Suppl 3):P326

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P19-04. A synergistic effect of a combined bivalent DNA-protein anti-HIV-1 vaccine containing multiple T- and B-cell epitopes of HIV-1 proteins

Authors: A Ilyichev, L Karpenko, L Lebedev, R Uzhachenko, T Ilyicheva and S Bazhan

Citation: Retrovirology 2009 6(Suppl 3):P324

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P17-12. Immunogenicity comparison of dna vaccines encompassing HIV-1 tat, rev, integrase (C-half), vif and nef genes derived from different clades

Authors: Y Wan, C Zhang, J Shi, C Qiu, S Yuan and J Xu

Citation: Retrovirology 2009 6(Suppl 3):P294

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P17-10. A new AuxoGTU-HIV B DNA vaccine induce very long lasting HIV specific T cells response which is efficiently boosted with HIV LAI lipopeptides

Authors: I Mangeot-Méderlé, N Sylla, A Corneau, S Langlois, R Sikut, K Kaldma, I Stanescu, M Ustav, Y Lévy, N Derreudre-Bosquet, R Le-Grand and F Martinon

Citation: Retrovirology 2009 6(Suppl 3):P292

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P17-06. Development of a replication-defective Herpes Simplex virus 1 recombinant expressing HIV-1 clade A envelope protein

Authors: J Sen, X Liu, L Mathews, K Bryant and D Knipe

Citation: Retrovirology 2009 6(Suppl 3):P288

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P16-32. Antigen exposure regulates the balance between proliferating and cytotoxic subsets of virus-specific CD8 T-cells

Authors: C Cellerai, M Perreau, V Rozot, F Bellutti Enders, P Bart, G Pantaleo and A Harari

Citation: Retrovirology 2009 6(Suppl 3):P261

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P16-28. The first year: early correlates of long-term HIV progression

Authors: PK Chattopadhyay, T Brodie, A Ganesan, JR Mascola, NL Michael and M Roederer

Citation: Retrovirology 2009 6(Suppl 3):P257

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P16-26. High avidity virus-specific CD4+ T cells are lost during retroviral infection due to interaction with B cells

Authors: MJ Ploquin, R Pike and G Kassiotis

Citation: Retrovirology 2009 6(Suppl 3):P255

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P16-24. Crucial contribution of sub-dominant HLA-C allele restricted CTL responses to the control of HIV

Authors: J Ibarrondo, R Zúñiga, M Farfán, J Suarez, B Mothe, A Llano, JJ Szinger, W Hildebrand, J Sánchez, BT Korber and C Brander

Citation: Retrovirology 2009 6(Suppl 3):P253

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P16-20. TB co-infection is associated with increased cytotoxic phenotype marker expression on CD8+ T lymphocytes, but reduced HIV-specific degranulation

Authors: ST Pillay, D de Swardt, J Kabue and RH Glashoff

Citation: Retrovirology 2009 6(Suppl 3):P249

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P15-21. Investigating the utility and relevance of the good participatory practice guidelines for biomedical HIV prevention trials

Authors: L Miller, E Bass, M Warren, K Fisher, D Grant and C Feuer

Citation: Retrovirology 2009 6(Suppl 3):P222

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P15-19. Evaluating community engagement efforts in a large, multi-site, global HIV vaccine trials network

Authors: K Maggard, G Broder, E Maclachlan and A None

Citation: Retrovirology 2009 6(Suppl 3):P220

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P15-17. Social media as a tool for engaging and educating audiences around HIV vaccine research and clinical trial participation

Authors: S Sitar, BI Hartman, BS Graham and JE Ledgerwood

Citation: Retrovirology 2009 6(Suppl 3):P218

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P15-15. Advocates' perspectives on community engagement in the HVTN 505

Authors: M Warren, E Bass, C Feuer, K Fisher, D Grant and L Miller

Citation: Retrovirology 2009 6(Suppl 3):P216

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P14-02. Social impact events in Phambili, the first phase 2B HIV vaccine trial in South Africa

Authors: MA Allen, G Gray, G Churchyard, L Bekker, M Nchabeleng, K Mlisana, B Metch, Z Moodie, S Roux, M Mathebula, T Bennie and J Kublin

Citation: Retrovirology 2009 6(Suppl 3):P190

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P13-04. HIV positive women empowerment is equal to hiv prevalence reduction

Authors: MM Akolo, J Kimani, S Barassa, S Lipesa and I Gelmon

Citation: Retrovirology 2009 6(Suppl 3):P186

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P13-02. Cytoskeletal proteins bound to HSP70 may elicit resistance to SIV infection of CD4+ T cells

Authors: L Bergmeier, K Babaahmady, J Pido-Lopez, K Heesom, CG Kelly, T Whittall and T Lehner

Citation: Retrovirology 2009 6(Suppl 3):P184

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P12-16. Biochemical and immunological characterization of the plant-derived candidate HIV-1 mucosal vaccine CTB-MPR

Authors: N Matoba, I Cherni, S Kessans, J Frater, K Preston, M Bomsel and TS Mor

Citation: Retrovirology 2009 6(Suppl 3):P182

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P12-12. Analysis of antibody and B cell responses following inoculation with computationally designed HIV-1 2F5 epitope scaffold proteins

Authors: P Dosenovic, J Guenaga, G Ofek, D Baker, W Schief, PD Kwong, GB Karlsson Hedestam and RT Wyatt

Citation: Retrovirology 2009 6(Suppl 3):P178

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P11-06. Intravaginal administration of HIV-1ZM96 gp140 augments systemic and mucosal antibody responses following systemic priming with adjuvanted protein

Authors: M Cranage, C Fraser, A Cope, P McKay, W Elsley, M Page, AN Mahmoud, K DaCosta, P Fletcher, N Armanasco, N Almond and R Shattock

Citation: Retrovirology 2009 6(Suppl 3):P151

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P11-04. PEGylated poly [2-(N,N-dimethylamino) ethyl methacrylate] as mucosal DNA delivery vector improves HIV-1-specific immune responses

Authors: Y Qiao, Y Huang, XY Yue, C Qiu, LD Deng, YM Wan, JF Xing, CY Zhang, SH Yuan, AJ Dong and JQ Xu

Citation: Retrovirology 2009 6(Suppl 3):P149

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P11-02. In situ analysis by confocal microscopy of the cellular components of mucosal tissues within the framework of preclinical vaccine studies

Authors: CA Boggiano, AA Ginsberg, MR Reynolds, NA Wilson, DI Watkins and AB McDermott

Citation: Retrovirology 2009 6(Suppl 3):P147

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P10-14. Dynamic profiling and correlation analysis of plasma viral load and cytokine and chemokine profiles in acute HIV-1 infection

Authors: L Qin, A Stacey, P Norris, P Wang, P Borrow and SG Self

Citation: Retrovirology 2009 6(Suppl 3):P145

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P09-01. Mutation of the gp120 alpha2 helix in early subtype C HIV-1 infection fails to alter neutralization sensitivity or efficiency of in vitro replication

Authors: MK Murphy, R Rong, B Li, J Mulenga, SA Allen, S Gnanakaran and CA Derdeyn

Citation: Retrovirology 2009 6(Suppl 3):P114

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P08-04. The role of class I HLA-B and HLA-Cw in disease progression and maternal-infant HIV-1 transmission in a South African population

Authors: M Paximadis, G Minevich, R Winchester, DB Schramm, GE Gray, GG Sherman, AH Coovadia, L Kuhn and CT Tiemessen

Citation: Retrovirology 2009 6(Suppl 3):P112

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P08-02. Genetic variation within the gene encoding the HIV-1 CCR5 coreceptor in two South African population groups

Authors: AC Picton, M Paximadis and CT Tiemessen

Citation: Retrovirology 2009 6(Suppl 3):P110

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P07-10. Natural compounds in bodily fluids which bind DC-SIGN and prevent HIV-1 capture and transfer to CD4 cells

Authors: MJ Stax, G Pollakis, RR Sprenger, M Melchers, T van Montfort, RW Sanders, D Speijer and WA Paxton

Citation: Retrovirology 2009 6(Suppl 3):P108

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P07-08. Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells

Authors: F Remes Lenicov, J Sabatté, C Rodríguez Rodrígues, M Cabrini, C Jancic, S Raiden, M Donalson, R Pasqualini, C Marin-Briggiler, M Vásquez-Levin, F Capani, S Amigorena, J Geffner and A Ceballos

Citation: Retrovirology 2009 6(Suppl 3):P106

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P05-04. Neutralizing antibodies induced by immunization with liposomal gp41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes

Authors: GR Matyas, L Wieczorek, Z Beck, C Ochsenbauer-Jambor, JC Kappes, NL Michael, VR Polonis and CR Alving

Citation: Retrovirology 2009 6(Suppl 3):P80

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P04-48. HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after gp120 protein vaccination or chronic HIV-1 infection

Authors: M Bonsignori, MA Moody, RJ Parks, TM Holl, G Kelsoe, CB Hicks, N Vandergrift, GD Tomaras and BF Haynes

Citation: Retrovirology 2009 6(Suppl 3):P76

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P04-46. Broadly cross-neutralizing activity in plasma of HIV-1 and HIV-2 infected individuals

Authors: E Fenyö, B Holmgren, ZJ da Silva, J Nielsen, P Aaby and M Jansson

Citation: Retrovirology 2009 6(Suppl 3):P74

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P04-15. Prevalence of broadly neutralizing antibody responses during acute/early HIV infection

Authors: I Mikell, D Sather, S Kalams, M Altfeld and L Stamatatos

Citation: Retrovirology 2009 6(Suppl 3):P43

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P04-13. Complex pattern of neutralization of cell-to-cell HIV transmission to activated CD4+T cells

Authors: M Massanella, I Puigdomènech, J Carrillo, B Clotet and J Blanco

Citation: Retrovirology 2009 6(Suppl 3):P41

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P04-11. Prevalence of neutralizing antibody responses in chronic clades A and D human immunodeficiency virus type 1 (HIV-1) infections

Authors: HF Njai, K Tomusange, B Sokolik-Wolak, D Montefiori, S Balla, G Vanham, J Levin, D Maher, A Kamali, H Grosskurth, P Pala and P Kaleebu

Citation: Retrovirology 2009 6(Suppl 3):P39

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P04-09. Induction of cross-clade neutralizing antibodies with a prime/boost vaccine strategy focused on a neutralizing epitope

Authors: S Zolla-Pazner, X Kong, T Cardozo, C Hioe, S Cohen, X Jiang, MK Gorny, M Totrov, A Pinter, C Krachmarov, MS Seaman, S Wang and S Lu

Citation: Retrovirology 2009 6(Suppl 3):P37

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
P04-07. Guiding the immune system through complex maturation pathways: a novel multi-immunogen approach for elicitation of broadly neutralizing antibodies

Authors: X Xiao, Y Feng, W Chen, N Longo and DS Dimitrov

Citation: Retrovirology 2009 6(Suppl 3):P35

Content type: Poster presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
OA05-03. Efficacy study of a T-cell-based DNA vaccine delivered by intradermal electrotransfer in macaques

Authors: N Dereuddre-Bosquet, M Baron, I Méderlé-Mangeot, K Kaldma, R Sikut, A Männik, I Stanescu, M Ustav, R Le Grand and F Martinon

Citation: Retrovirology 2009 6(Suppl 3):O33

Content type: Oral presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers

Authors: S Vasan, A Hurley, SJ Schlesinger, D Hannaman, DF Gardiner, DP Dugin, MM Boente-Carrera, RM Vittorino, M Caskey, J Andersen, Y Huang, J Cox, T Tarragona, DK Gill, H Cheeseman, L Clark…

Citation: Retrovirology 2009 6(Suppl 3):O31

Content type: Oral presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
OA04-05. Safety and viral load changes in HIV-1 infected subjects treated with autologous dendritic immune therapy following ART discontinuation (CTN#239)

Authors: J Routy, M Boulassel, L Mona, V Sylvie, T Cécile, A Jonathan, G John, B Jean-Guy, S Fiona, J Renu, H Don, T Irina, N Charles and RP Sékaly

Citation: Retrovirology 2009 6(Suppl 3):O29

Content type: Oral presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF
OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial

Authors: JR Currier, M De Souza, S Ratto-Kim, R Paris, V Nguay, J Cox, P Earl, B Moss, S Sriplienchan, P Thongcharoen, J Kim, M Robb, N Michael and M Marovich

Citation: Retrovirology 2009 6(Suppl 3):O27

Content type: Oral presentation Published on: 22 October 2009

This article is part of a Supplement: Volume 6 Supplement 3
- View Full Text
- View PDF

How was your experience today?

Rating Please select one rating

Awful

Bad

Good

Great

Thank you for your feedback.

Tell us why (opens in a new tab)

Articles

Follow

Annual Journal Metrics

Retrovirology

Contact us